Zevra therapeutics announces u.s. commercial availability of miplyffa™ (arimoclomol) for treatment of niemann-pick disease type c

Miplyffa, the first fda-approved treatment for niemann-pick disease type c, is available at zevra's specialty pharmacy for dispense

ZVRA Ratings Summary

ZVRA Quant Ranking